Step On The Box

Biomarkers for cardiovascular disease

We are looking for:
Students in health, medical engineering, biomedical sciences/engineering, technology, business

Status
Finished
Spots
8 available
Registration deadline
12 Nov 2022
Sprintday
15 Nov 2022
Location
Gedempt Hamerkanaal 111, 1021 KP Amsterdam, Netherlands, Onsite
1. Description of the challenge

It is expected that 1 out of 5 people have elevated levels of a biomarker called lipoprotein(a).
These people have significant increased risks on cardiovascular disease. The key problem is that while so many people suffer from this condition, almost nobody knows, because very few people are tested for lipoprotein(a).

2. Expected outcome

Out-of-the box and creative ideas to increase testing in the Netherlands for lipoprotein(a).

About Novartis Pharma BV

Our purpose is to reimagine medicine to improve and extend people's lives. We use innovative science and technology to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.